A - Human Necessities – 61 – P
Patent
A - Human Necessities
61
P
A61P 27/12 (2006.01)
Patent
CA 2611102
The invention provides a method to treat or prevent posterior capsular opacification. The method comprises administering a therapeutically or prophylactically effective amount of a pharmaceutical composition comprising at least one kinase inhibitor. The kinase inhibitor inhibits p38 kinases, ERK kinases, and/ or Src family kinases. The invention also provides an ocular device coated with at least one kinase inhibitor.
La présente invention concerne un procédé de traitement et de prévention de l'opacification de la capsule postérieure. Ce procédé consiste administrer une quantité thérapeutiquement ou prophylactiquement efficace d'une composition pharmaceutique comprenant au moins un inhibiteur de kinase. Cet inhibiteur de kinase inhibe des kinases p38, des kinases ERK et/ou des kinases de la famille Src. Cette invention concerne aussi un dispositif oculaire revêtu avec au moins un inhibiteur de kinase.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Thomas Jefferson University
LandOfFree
Method to treat and prevent posterior capsule opacification does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method to treat and prevent posterior capsule opacification, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to treat and prevent posterior capsule opacification will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2033025